Jo‐Anne Wilson - Concepedia

Author

Jo‐Anne Wilson

Also Known As

E Stokes, G Stott, Jo-Anne S Wilson, Jo-Anne S. Wilson, Jo-Anne Wilson, JoAnne Wilson, Jo‐Anne S. Wilson, Jo‐Anne Wilson, S Jo-Anne Wilson, S. JO-ANNE WILSON

Publications

719

Citations

H-Index

Concepts

All Affiliations

Dalhousie University Nova Scotia Health Authority Queen Elizabeth II Health Sciences Centre University of British Columbia University of Calgary

About

Jo‐Anne Wilson is an author at Dalhousie University specializing in medicine, public health, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	161
2	Public Health	3	3	85
3	Emergency Medicine	1	1	19
4	Health Policy	1	1	37
5	Medical Laboratory Science	1	1	29

Jo‐Anne Wilson

Publications

569

Citations

H-Index

Page 1

	Year	Citations
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Jo‐Anne Wilson, Philip S. Wells, Michael J. Kovacs, PubMed	2003	196
Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism Jo‐Anne Wilson, Kerry Wilbur, Erica Burton, Pathophysiology of Haemostasis and Thrombosis	2001	97
Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD Louise Moist, Stéphan Troyanov, Colin T. White, American Journal of Kidney Diseases GlomerulonephritisHemodialysisCanadian SocietyRenal DiseaseRenal Function	2013	76
Direct and indirect costs of management of long‐term warfarin therapy in Canada Sam Schulman, David R. Anderson, Tammy J. Bungard, Journal of Thrombosis and Haemostasis ThrombosisIndirect CostsHealth EconomicsHealth PolicyHealth Care Reimbursement	2010	37
COMPARISON OF A NOMOGRAMAND PHYSICIAN-ADJUSTED DOSAGE OF WARFARIN FOR PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ARTHROPLASTY David R. Anderson, Jo‐Anne Wilson, J Blundell, Journal of Bone and Joint Surgery	2002	32
An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis Jo‐Anne Wilson, Kerry B. Goralski, Steven D. Soroka, The Journal of Clinical Pharmacology Dabigatran EtexilateDialysis TherapyPharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacokinetics	2014	29
Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy Melissa J. Lefebvre, Patrick Ng, Arlene Desjarlais, Canadian Journal of Kidney Health and Disease	2020	29
Oral Sodium Thiosulfate as Maintenance Therapy for Calcific Uremic Arteriolopathy: A Case Series Meteb M. AlBugami, Jo‐Anne Wilson, James R. Clarke, American Journal of Nephrology	2013	26
A Model for Perioperative Outpatient Management of Anticoagulation in High-Risk Patients: An Evaluation of Effectiveness and Safety Jo‐Anne Wilson, Jennifer Morgan, Lisa Gray, The Canadian Journal of Hospital Pharmacy Heart FailurePharmacotherapyPost-operative CareThrombosisVenous Thrombosis	2001	19
Ambulatory Medication Reconciliation in Dialysis Patients: Benefits and Community Practitioners’ Perspectives Jo‐Anne Wilson, Matthew Ladda, Jaclyn Tran, The Canadian Journal of Hospital Pharmacy	2017	14

Page 1